|
PRME Prime Medicine, Inc 1894562 |
| Balance Sheet |
|
Current Assets
|
$96,804,000.00 |
|
Assets
|
$249,040,000.00 |
|
Current Liabilities
|
$31,692,000.00 |
|
Liabilities
|
$209,231,000.00 |
|
Equity
|
$39,809,000.00 |
|
Shares Out
|
180737548.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-83,756,000.00 |
|
Investing Cash Flow
|
$67,421,000.00 |
| Market Analysis |
Market Cap
|
$585,589,655.52 |
|
Price
|
$3.24 |
|
BVPS
|
0.22 |
|
PB
|
14.73 |
|
EPS
|
-0.24 |
|
PS
|
126.42 |
|
FCF
|
$-84,016,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:38 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:29 |
| Apr |
May |
Jun |
| 2026-03-03 |
-1.35 |
|
|
2026-05-07 |
-0.28 |
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-07 |
-0.41 |
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-07 |
-0.32 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view PRME documents filed with the SEC.
PRME Filings
Clear